According to Genetic Technologies's latest financial reports the company has โฌ0.66 Million in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-06-30 | โฌ4.78 M | -38.11% |
2022-06-30 | โฌ7.72 M | -41.44% |
2021-06-30 | โฌ13.19 M | 51.94% |
2020-06-30 | โฌ8.68 M | 560.79% |
2019-06-30 | โฌ1.31 M | -62.16% |
2018-06-30 | โฌ3.47 M | -52.96% |
2017-06-30 | โฌ7.38 M | -1.66% |
2016-06-30 | โฌ7.5 M | -40.14% |
2015-06-30 | โฌ12.54 M | 541.21% |
2014-06-30 | โฌ1.95 M | 44.21% |
2013-06-30 | โฌ1.35 M | -81.2% |
2012-06-30 | โฌ7.21 M | 91.31% |
2011-06-30 | โฌ3.77 M | 65.83% |
2010-06-30 | โฌ2.27 M | -49.4% |
2009-06-30 | โฌ4.49 M | -45.02% |
2008-06-30 | โฌ8.17 M | -2.66% |
2007-06-30 | โฌ8.39 M | 35.69% |
2006-06-30 | โฌ6.18 M | -44.46% |
2005-06-30 | โฌ11.14 M | 73.4% |
2004-06-30 | โฌ6.42 M | 81.53% |
2003-06-30 | โฌ3.54 M | -12.6% |
2002-06-30 | โฌ4.05 M | 940.43% |
2001-06-30 | โฌ0.38 M | -49.62% |
2000-06-30 | โฌ0.77 M |